OMGAQ — Omega Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Omega Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2.27	23	225	125	73.4
Net Total Accounts Receivable
Net Total Receivables	0.005	0.193	0.521	1.8	6.99
Prepaid Expenses
Total Current Assets	2.65	24	229	138	89.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.83	3.48	3.6	7.86	114
Other Long Term Assets
Total Assets	6.12	28.1	233	146	204
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.23	7.7	12	22	26.8
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	15.3	17.5	32.7	40	146
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-9.21	10.6	201	106	58
Total Liabilities & Shareholders' Equity	6.12	28.1	233	146	204
Total Common Shares Outstanding